Clinical and Commercial Development

The Clinical and Commercial Development team at Aldeyra Therapeutics is responsible for advancing clinical trials, developing market access strategies, and translating scientific research into viable treatment options for aldehyde toxicity-related diseases such as Sjögren-Larsson Syndrome and noninfectious anterior uveitis. This team ensures that innovative therapies reach patients effectively by coordinating between clinical research, strategy development, and market implementation.